We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

New Cell Lines Produce NIST Monoclonal Antibody for Improved Biologic Drug Manufacturing

News   Aug 01, 2018 | Original story from the National Institute of Standards and Technology (NIST)

 
New Cell Lines Produce NIST Monoclonal Antibody for Improved Biologic Drug Manufacturing

HeLa cancer cells appear green wherever mouse monoclonal antibodies (mAb) have bound to tubulin, a structural protein important in cell division. Binding to tubulin and preventing cell growth is one way that mAb drugs could kill tumors—the type of research that may benefit from the use of NIST's monoclonal antibody reference material, NISTmAb. Credit: ©EnCor Biotechnology Inc.

 
 
 

RELATED ARTICLES

Hat Could One Day Reverse Baldness – And It's Cheap Too!

News

Few things on earth strike fear into the hearts of men more profoundly than hair loss. But reversing baldness could someday be as easy as wearing a hat, thanks to a noninvasive, low-cost hair-growth-stimulating technology developed by engineers at the University of Wisconsin–Madison.

READ MORE

A Cure for the Common Cold?

News

Disabling a single, apparently noncritical protein in cells may foil replication of the viruses that cause half of all common colds, polio and other diseases.

READ MORE

New Study of HIV Vaccine Shows Promising Results Across Strains

News

Using the same RV 144 HIV vaccine employed in Thailand, a new study has evaluated whether the vaccine-induced immune responses to RV 144 are similar in a South African cohort.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE